These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10545714)

  • 41. [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives].
    Delvaux M; Frexinos J
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C42-53. PubMed ID: 11787379
    [No Abstract]   [Full Text] [Related]  

  • 42. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New and future drugs in nerve-gut dysfunction.
    Bueno L
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):794-801. PubMed ID: 10730572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of serotonin in the pathophysiology of the irritable bowel syndrome.
    Crowell MD
    Br J Pharmacol; 2004 Apr; 141(8):1285-93. PubMed ID: 15100164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds.
    Callahan MJ
    J Clin Gastroenterol; 2002 Jul; 35(1 Suppl):S58-67. PubMed ID: 12184141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensory dysfunction and the irritable bowel syndrome.
    Houghton LA
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):415-27. PubMed ID: 10580918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome.
    Mangel AW; Hahn BA; Heath AT; Northcutt AR; Kong S; Dukes GE; McSorley D
    J Int Med Res; 1998; 26(2):76-81. PubMed ID: 9602985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel.
    Gershon MD
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():15-30. PubMed ID: 10429737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin and its implication for the management of irritable bowel syndrome.
    Gershon MD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S25-34. PubMed ID: 12776000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes.
    Hughes PA; Harrington AM; Castro J; Liebregts T; Adam B; Grasby DJ; Isaacs NJ; Maldeniya L; Martin CM; Persson J; Andrews JM; Holtmann G; Blackshaw LA; Brierley SM
    Gut; 2013 Oct; 62(10):1456-65. PubMed ID: 22767422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enteric P2X receptors as potential targets for drug treatment of the irritable bowel syndrome.
    Galligan JJ
    Br J Pharmacol; 2004 Apr; 141(8):1294-302. PubMed ID: 15051631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.
    Camilleri M; Northcutt AR; Kong S; Dukes GE; McSorley D; Mangel AW
    Lancet; 2000 Mar; 355(9209):1035-40. PubMed ID: 10744088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review article: evaluation of drugs in experimental gut distension models.
    Pappas TN; Mangel AW; Lawson C
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():54-6. PubMed ID: 10429741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Migraine and irritable bowel syndrome].
    Mulak A; Paradowski L
    Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S55-60. PubMed ID: 16419571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC; Dong L; Wang Y; Wang SH; Cao MB
    Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional abdominal pain: the basic science.
    Wood JD
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):688-93. PubMed ID: 18955879
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacologic therapy for the irritable bowel syndrome.
    Talley NJ
    Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation.
    Blackshaw LA; Brierley SM
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):15-9. PubMed ID: 23859756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.